Transthyretin mutations in hyperthyroxinemia and amyloid diseases

Authors
Citation
Mjm. Saraiva, Transthyretin mutations in hyperthyroxinemia and amyloid diseases, HUM MUTAT, 17(6), 2001, pp. 493-503
Citations number
116
Categorie Soggetti
Molecular Biology & Genetics
Journal title
HUMAN MUTATION
ISSN journal
10597794 → ACNP
Volume
17
Issue
6
Year of publication
2001
Pages
493 - 503
Database
ISI
SICI code
1059-7794(2001)17:6<493:TMIHAA>2.0.ZU;2-A
Abstract
Over 80 different disease causing mutations in transthyretin (TTR) have bee n reported. The vast majority are inherited in an autosomal dominant manner and are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart. A small portion of TTR mutations are apparently non amyloidogenic. Among these are mutations responsible for hyperthyroxinemia , presenting high affinity for thyroxine (a TTR ligand), Compound heterozyg otic individuals for TTR mutants have been described; noteworthy is the cli nically protective effect exerted by a non pathogenic over a pathogenic mut ation. Current TTR mutations and their significance are briefly reviewed he re. Hum Mutat 17:493-503, 2001. (C) 2001 Wiley-Liss, Inc.